| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -507 | 212 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 54 | 60 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 139 | 542 |
| Cash and cash equivalents at beginning of period | 1,201 | - |
| Cash and cash equivalents at end of period | 1,340 | - |
Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC)